![Pieter Spee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pieter Spee
Hoofd Techniek/Wetenschap/O&O bij
PURE BIOLOGICS S.A.
Profiel
Pieter Spee is currently the Chief Scientific Officer at Pure Biologics SA since 2023.
Prior to this, he worked as the Scientific Director-Translational Immunology at Novo Nordisk A, Chief Scientific Officer at TikoMed AB, and Chief Technology Officer at FibroTx OÜ.
He obtained his doctorate degree from the University of Leiden in 1996.
Actieve functies van Pieter Spee
| Bedrijven | Functie | Begin |
|---|---|---|
| PURE BIOLOGICS S.A. | Hoofd Techniek/Wetenschap/O&O | 26-05-2023 |
Eerdere bekende functies van Pieter Spee
| Bedrijven | Functie | Einde |
|---|---|---|
FibroTx OÜ | Hoofd Techniek/Wetenschap/O&O | - |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Opleiding van Pieter Spee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pure Biologics SA
 Pure Biologics SA BiotechnologyHealth Technology Operates as a a biopharmaceutical company which develops biological medicines, diagnostic tests and medical devices with therapeutic use | Health Technology |
FibroTx OÜ |
